Skip to main content
Log in

Adriamycin-induced activation of NK activity may initially involve LAF production

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

C3HeB/FeJ spleen cells (unseparated or passaged over nylon wool columns) were cultured overnight (1∓2×106 cells/microwell) in the presence and absence of resident or ADM-induced PEC and anti-YAC-1 (4 h) NK activity was determined. The addition of resident PEC to spleen cells had little effect on NK activity. However, the addition of ADM-elicited PEC (10 mg/kg, IP, day −1 and day −5) to spleen cells prior to culture significantly augmented NK activity. If ADM-induced PEC were treated with carbonyl iron prior to coculture with spleen cells, augmentation of anti-YAC-1 activity was not observed. This suggested that ADM-activated macrophages augmented cultured splenic NK activity. Supernatants from overnight-cultured resident or ADM-induced adherent PEC were then prepared, dialyzed (to remove ADM), and tested for mitogenic activity or cocultured with spleen cells overnight. ADM-induced adherent PEC supernatants stimulated the proliferation of murine thymocytes (both LAF and IL-2 also stimulate) but not cultured CTL (only IL-2 stimulates). ADM-induced adherent PEC supernatants (as well as LAF, IL-2, and IFN) augmented overnight-cultured C3HeB/FeJ splenic NK activity. However, only IL-2 and IFN could augment overnight-cultured athymic BALB/c · nu/nu splenic NK activity. This suggested that ADM-elicited macrophages produce LAF which may act directly on NK cells or, more likely, may induce T cells to produce IL-2, IFN, or both.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chun MC, Fernandes G, Hoffmann MK (1981) Mechanism of NK cell activation: Relationship between Qa5 NK cells and lymphocytes. J Immunol 126:331

    Google Scholar 

  2. Cohen SA, Ehrke MJ, Ryoyama K, Mihich E (1982a) Augmentation of the phagocytic activity of murine spleen cell populations induced by adriamycin. Immunopharmacology 5:75

    Google Scholar 

  3. Cohen SA, Salazar D, Kaminski D (1982b) Augmentation of murine natural killer activity after culture. J Immunol Methods 48:359

    Google Scholar 

  4. Dempsey RA, Dinarello CA, Mier JM, Rosenwasser LJ, Allegretta M, TE, Parkinson, DR (1982) The differential effects of human leukocytic pyrogen/lymphocyte-activating factor, T cell growth factor, and Interferon on human natural killer activity. J Immunol 129:2504

    Google Scholar 

  5. Djeu J, Heinbaugh JA, Holden HT, Herbermann RB (1979) Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 122:175

    Google Scholar 

  6. Ehrke MJ, Cohen SA, Mihich E (1982) Selective effects of adriamycin on murine host defense systems. Immunol Rev 65:55

    Google Scholar 

  7. Fachinetti T, Raz A, Goldman R (1978) A differential interaction of daunomycin, adriamycin, and N-trifluoroacetyladriamycin 14-valerate with mouse peritoneal macrophages. Cancer Res 38:3944

    Google Scholar 

  8. Farrar WL, Mizel SB, Farrar JJ (1980) Participation of lymphocyte-activating factor (interleukin-1) in the induction of cytotoxic T cell responses. J Immunol 124:1371

    Google Scholar 

  9. Farrar WL, Johnson HM, Farrar JJ (1981) Regulation of the production of immune interferon and cytotoxic T lymphocytes by Interleukin 2. J Immunol 126:1120

    Google Scholar 

  10. Gery IR, Handschumacher RE (1974) Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells. Cell Immunol 11:162

    Google Scholar 

  11. Gery I, Gershon RK, Waksman B (1972) Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med 136:128

    Google Scholar 

  12. Gery I, Davies P, Derr J, Krett N, Barranger JA (1981) Relationship between production and release of lymphocyte activating factor (Interleukin I) by murine macrophages. I. Effects of various agents. Cell Immunol 64:293

    Google Scholar 

  13. Gillis S, Union NA, Baker PE, Smith KA (1979) The in vitro generation and sustained culture of nude mouse cytolytic T-cell lymphocytes. J Exp Med 152:698

    Google Scholar 

  14. Haskill JS (1981) Adriamycin-activated macrophages as tumor growth inhibitors. Cancer Res 41:3852

    Google Scholar 

  15. Henney CS, Kuribayashi K, Kern DE, Gillis S (1981) IL-2 augments NK selectivity. Nature 291:335

    Google Scholar 

  16. Herberman RB, Nunn ME, Lavrin DH (1975) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16:216

    Google Scholar 

  17. Julius MH, Simpson E, Herzenberg LA (1973) A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 3:645

    Google Scholar 

  18. Karre K, Seeley J (1979) Cytotoxic Thy 1.2-positive blasts with NK-like target selectivity in murine mixed lymphocyte cultures. J Immunol 123:1511

    Google Scholar 

  19. Kuribayashi K, Gillis S, Kern DE, Henney CS (1981) Murine NK cell cultures: Effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol 126:2321

    Google Scholar 

  20. Larson EL, Iscove NN, Coutinho A (1980) Two distinct factors are required for induction of T-cell growth. Nature 283:664

    Google Scholar 

  21. Lundgren G, Zukosi CF, Moller G (1968) Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol 3:817

    Google Scholar 

  22. Mantovani A (1977) In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages. Cancer Res 37:815

    Google Scholar 

  23. Mizel SB (1982) Interleukin-1 and T cell activation. Immunol Rev 63:51

    Google Scholar 

  24. Riccardi C, Puccetti P, Santoni A, Herberman RB, Bonmasser E (1979) Adriamycin-induced antitumor response in lethally irradiated mice. Immunopharmacology 1:211

    Google Scholar 

  25. Ruscetti FW, Morgan DA, Gallo RC (1977) Functional and morphologic characterization of human T cells continuously growing in vitro. J Immunol 119:131

    Google Scholar 

  26. Santoni A, Richardi C, Sorci V, Herberman RB (1980) Effects of adriamycin on the activity of mouse natural killer cells. J Immunol 124:2329

    Google Scholar 

  27. Smith KA, Lachmann LB, Oppenheim JJ, Fanta MF (1980) The functional relationship of the interleukins. J Exp Med 151:1551

    Google Scholar 

  28. Stoyckov JN, Schultz RM, Chirigos MA, Pavlidis NA, Goldin A (1979) Effects of adriamycin and cyclophosphamide treatment on induction of macrophage cytotoxic function in mice. Cancer Res 39:3014

    Google Scholar 

  29. Tracey DE (1979) The requirement for macrophages in the augmentation of natural killer cell activity by BCG. J Immunol 123:840

    Google Scholar 

  30. Welsh RM, Doe WF (1980) Cytotoxic cell induced during lymphocytic choriomeningitis virus infection of mice. Natural killer cell activity in cultured spleen leukocytes concominant with T-cell-dependent immune interferon production. Infect Immun 30:473

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Abbreviations used in this paper: ADM, Adriamycin; NK, natural killer; PEC, peritoneal exudate cells; BCG, Bacillus Calmette-Guérin; LAF, lymphocyte-activating factor; IL-1, interleukin I; ppTCGF, partially; purified T cell growth factor; IL-2, interleukin 2; IFN, murine interferon; CTL, cytotoxic T lymphocytes; PMA, phorbal myristate acetate; ADM-PEC-Sup; adriamycin-elicited PEC supernatant; FCS, fetal calf serum; Indo, indomethacin; Ad, adherent

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, S.A., Salazar, D. & Wicher, J. Adriamycin-induced activation of NK activity may initially involve LAF production. Cancer Immunol Immunother 15, 188–193 (1983). https://doi.org/10.1007/BF00199163

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199163

Keywords

Navigation